Mary Wells in Omaha, Nebraska

Medical School: Sorry, her university is not listed
Graduation Year: 2016
The Primary Medical Specialty for Mary Wells is listed as: Hematology/oncology
Approximate Years of Experience: 8
PAC (PECOS ID)#: 2567686611
NPI #: 1538508296
NPI Created On: 06/17/2013
NPI Last Updated Listed as: 09/10/2020
Primary Taxonomy Code: 207R00000X
License Number:
6963
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Medica Insurance Company
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English.

Services and Procedures include:

1. Complete blood cell count (red cells, white blood cell, platelets), automated test
2. Vaccine for influenza for injection into muscle
3. Hydration infusion into a vein
4. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
5. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
6. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
7. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
8. Infusion of chemotherapy into a vein up to 1 hour
9. Irrigation of implanted venous access drug delivery device
10. New patient office or other outpatient visit, typically 60 minutes
11. Established patient office or other outpatient visit, typically 15 minutes
12. Established patient office or other outpatient, visit typically 25 minutes
13. Established patient office or other outpatient, visit typically 40 minutes
14. Subsequent hospital inpatient care, typically 25 minutes per day
15. Administration of influenza virus vaccine
16. Oncology care model (ocm) monthly enhanced oncology services (meos) payment for ocm enhanced services. g9678 payments may only be made to ocm practitioners for ocm beneficiaries for the furnishment of enhanced services as defined in the ocm participation a
17. Injection, dexamethasone sodium phosphate, 1 mg
18. Injection, ondansetron hydrochloride, per 1 mg
19. Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram